Find Methdilazine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Tacaryl, 1982-37-2, Methdilazinum, Tacazyl, Methdilazinum [inn-latin], Metodilazina [inn-spanish]
Molecular Formula
C18H20N2S
Molecular Weight
296.4  g/mol
InChI Key
HTMIBDQKFHUPSX-UHFFFAOYSA-N
FDA UNII
4Q13LY9Z8X

Methdilazine
Methdilazine is a phenothiazine compound with antihistaminic activity. It is used in the treatment of various dermatoses to relieve pruritus.
1 2D Structure

Methdilazine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
10-[(1-methylpyrrolidin-3-yl)methyl]phenothiazine
2.1.2 InChI
InChI=1S/C18H20N2S/c1-19-11-10-14(12-19)13-20-15-6-2-4-8-17(15)21-18-9-5-3-7-16(18)20/h2-9,14H,10-13H2,1H3
2.1.3 InChI Key
HTMIBDQKFHUPSX-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN1CCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42
2.2 Other Identifiers
2.2.1 UNII
4Q13LY9Z8X
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Methdilazine Hydrochloride

2.3.2 Depositor-Supplied Synonyms

1. Tacaryl

2. 1982-37-2

3. Methdilazinum

4. Tacazyl

5. Methdilazinum [inn-latin]

6. Metodilazina [inn-spanish]

7. Nci-c60720

8. 10-[(1-methylpyrrolidin-3-yl)methyl]phenothiazine

9. Methdilazine (inn)

10. 10-[(1-methylpyrrolidin-3-yl)methyl]-10h-phenothiazine

11. 10-((1-methyl-3-pyrrolidinyl)methyl)phenothiazine

12. 4q13ly9z8x

13. Chebi:6823

14. Methodilazine

15. Metodilazina

16. 10h-phenothiazine, 10-((1-methyl-3-pyrrolidinyl)methyl)-

17. 10h-phenothiazine, 10-[(1-methyl-3-pyrrolidinyl)methyl]-

18. Tacryl

19. Methdilazine [inn]

20. Nsc169091

21. Mj 5022

22. 10-[(1-methyl-3-pyrrolidinyl)methyl]phenothiazine

23. Phenothiazine, 10-((1-methyl-3-pyrrolidinyl)methyl)-

24. Phenothiazine, 10-[(1-methyl-3-pyrrolidinyl)methyl]-

25. 10-[(1-methyl-3-pyrrolidinyl)methyl]phenothiazine; Mj 5022

26. Tacaryl (tn)

27. Product 5022

28. Einecs 217-841-6

29. Metdilazina

30. Unii-4q13ly9z8x

31. Methdilazine [usp:inn:ban]

32. 10-((1-methyl-3-pyrrolidinyl)methyl)phenothiazine Monohydrochloride

33. Dilosyn (salt/mix)

34. Disyncram (salt/mix)

35. Disyncran (salt/mix)

36. 10h-phenothiazine, 10-((1-methyl-3-pyrrolidinyl)methyl)-, Monohydrochloride

37. Methdilazine [mi]

38. Methdilazine [vandf]

39. Methdilazine [mart.]

40. Methdilazine(200mg)

41. Methdilazine [who-dd]

42. Schembl121507

43. Gtpl7231

44. 10-((1-methyl-3-pyrrolidinyl)methyl)-10h-phenothiazine

45. Chembl1200959

46. Dtxsid6023282

47. Bdbm81470

48. Methdilazine (200 Mg)

49. Methdilazine [orange Book]

50. Hy-b1690

51. 10h-phenothiazine, Tannate (5:1)

52. Cas_14677

53. Nsc_14677

54. Nsc244191

55. Pdsp1_000149

56. Pdsp2_000148

57. Db00902

58. Nsc-244191

59. Nci60_001351

60. Cs-0013673

61. C07175

62. D04979

63. L001130

64. Sr-01000944494

65. Q6665709

66. Sr-01000944494-1

67. 10-[(1-methyl-3-pyrrolidinyl)methyl]-10h-phenothiazine #

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 296.4 g/mol
Molecular Formula C18H20N2S
XLogP35.2
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass296.13471982 g/mol
Monoisotopic Mass296.13471982 g/mol
Topological Polar Surface Area31.8 Ų
Heavy Atom Count21
Formal Charge0
Complexity339
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Used for the symptomatic relief of hypersensitivity reactions and particularly for the control of pruritic skin disorders


5 Pharmacology and Biochemistry
5.1 Pharmacology

In allergic reactions an allergen interacts with and cross-links surface IgE antibodies on mast cells and basophils. Once the mast cell-antibody-antigen complex is formed, a complex series of events occurs that eventually leads to cell-degranulation and the release of histamine (and other chemical mediators) from the mast cell or basophil. Once released, histamine can react with local or widespread tissues through histamine receptors. Histamine, acting on H1-receptors, produces pruritis, vasodilatation, hypotension, flushing, headache, tachycardia, and bronchoconstriction. Histamine also increases vascular permeability and potentiates pain. Methdilazine is a histamine H1 antagonist. It competes with histamine for the normal H1-receptor sites on effector cells of the gastrointestinal tract, blood vessels and respiratory tract. It provides effective, temporary relief of sneezing, watery and itchy eyes, and runny nose due to hay fever and other upper respiratory allergies.


5.2 ATC Code

R - Respiratory system

R06 - Antihistamines for systemic use

R06A - Antihistamines for systemic use

R06AD - Phenothiazine derivatives

R06AD04 - Methdilazine


5.3 Absorption, Distribution and Excretion

Absorption

Well absorbed in the digestive tract.


5.4 Mechanism of Action

Methdilazine binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty